Dr. Thomas Jensen obtained a MSc from the Danish Technical University of Denmark (DTU) in applied chemistry & chemical engineering in 2006. In 2009, he completed his PhD in synthetic organic chemistry from the DTU under the supervision of Professor Robert Madsen. From 2009 to 2010, Dr. Jensen conducted postdoctoral studies at the California Institute of Technology in the group of Professor Brian M. Stoltz focusing on synthesis. Since, 2011, he has been employed by H. Lundbeck A/S, where he works on small molecule CNS (Central Nervous System) drug discovery and contributes to drug discovery programs from hit identification to candidate selection. For the last four years, Dr. Jensen has led the medicinal chemistry efforts on drug discovery programs focusing on development of kinase inhibitors for CNS diseases. Furthermore, Dr. Jensen has managerial responsibility for one of the medicinal chemistry sections at H. Lundbeck A/S.